{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:38:19Z","timestamp":1793277499358,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xphs.2026.104549","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:57:13Z","timestamp":1792162633000},"page":"104549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Of mice and little humans: A comparison of the issues facing drug delivery to wildlife and pediatric patients"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-6805","authenticated-orcid":false,"given":"Arlene","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-590X","authenticated-orcid":false,"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2026.104549_bib0001","doi-asserted-by":"crossref","DOI":"10.1088\/1748-9326\/ac74d4","article-title":"Pandemics and the human-wildlife interface in Asia: land use change as a driver of zoonotic viral outbreaks","volume":"17","author":"Goldstein","year":"2022","journal-title":"Environ Res Lett"},{"key":"10.1016\/j.xphs.2026.104549_bib0002","series-title":"Share & Industry Analysis, By Product (Biologics, Pharmaceuticals), By Animal, By Route of Administration, By Drug Type, By Distribution Channel, and Regional Forecast","first-page":"2026","article-title":"Veterinary medicine market size","author":"Insights","year":"2026"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/mam.12347","article-title":"A review of bovine tuberculosis transmission risk in European wildlife communities","volume":"54","author":"Justus","year":"2024","journal-title":"Mamm Rev"},{"issue":"5","key":"10.1016\/j.xphs.2026.104549_bib0004","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/ani12050600","article-title":"Avian malaria in penguins: diagnostics and future direction in the context of climate change","volume":"12","author":"Ings","year":"2022","journal-title":"Animals"},{"issue":"8","key":"10.1016\/j.xphs.2026.104549_bib0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2460\/javma.243.8.1170","article-title":"Population pharmacokinetics of doxycycline in the tears and plasma of northern elephant seals (Mirounga angustirostris) following oral drug administration","volume":"243","author":"Freeman","year":"2013","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0061","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1638\/2014-0159R.1","article-title":"Pharmacokinetics of single-dose orally administered ciprofloxacin in California sea lions (Zalophus californianus)","volume":"46","author":"Barbosa","year":"2015","journal-title":"J Zoo Wildlife Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0052","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2460\/ajvr.78.3.267","article-title":"Pharmacokinetics of meloxicam after intramuscular and oral administration of a single dose to American flamingos (Phoenicopertus ruber)","volume":"78","author":"Boonstra","year":"2017","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104549_bib0044","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2460\/ajvr.2003.64.109","article-title":"Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus)","volume":"64","author":"Hunter","year":"2003","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0038","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1638\/2023-0080","article-title":"Pharmacokinetic profiles of oral phenylbutazone, meloxicam, and firocoxib in southern black rhinoceros (Diceros bicornis minor)","volume":"55","author":"Bryant","year":"2024","journal-title":"J Zoo Wildlife Med"},{"issue":"6","key":"10.1016\/j.xphs.2026.104549_bib0062","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jvp.12407","article-title":"Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration","volume":"40","author":"Gharibi","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0063","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1638\/2019-0200","article-title":"Pharmacokinetics of a single dose of fluralaner administered orally to American black bears (Ursus americanus)","volume":"51","author":"Van Wick","year":"2020","journal-title":"J Zoo Wildlife Med"},{"key":"10.1016\/j.xphs.2026.104549_bib0064","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fvets.2022.830157","article-title":"Ivermectin plasma concentration in Iberian ibex (Capra pyrenaica) following oral administration: a pilot study","volume":"9","author":"Moroni","year":"2022","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104549_bib0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2460\/ajvr.67.6.947","article-title":"Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna)","volume":"67","author":"Carpenter","year":"2006","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0066","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1099-1263(199905\/06)19:3<157::AID-JAT559>3.0.CO;2-K","article-title":"Pharmacokinetics of antipyrine, warfarin and paracetamol in the brushtail possum","volume":"19","author":"Eason","year":"1999","journal-title":"J Appl Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/ani13030428","article-title":"Fertility control for wildlife: a European perspective","volume":"13","author":"Massei","year":"2023","journal-title":"Animals"},{"issue":"S1","key":"10.1016\/j.xphs.2026.104549_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/emr.12461","article-title":"Fertility control for managing macropods \u2013 current approaches and future prospects","volume":"22","author":"Wimpenny","year":"2021","journal-title":"Ecol Manage Restor"},{"key":"10.1016\/j.xphs.2026.104549_bib0007","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fevo.2021.704809","article-title":"The promise of genetics and genomics for improving invasive mammal management on islands","volume":"9","author":"Burgess","year":"2021","journal-title":"Front Ecol Evol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0008","article-title":"Factors affecting pharmacokinetic parameters and their implication for drug efficacy and safety in veterinary science","volume":"1","author":"Mitiku","year":"2026","journal-title":"Vet J: Pharmacol Toxicol"},{"key":"10.1016\/j.xphs.2026.104549_bib0009","series-title":"Comparative and Veterinary Pharmacology","first-page":"139","article-title":"Interspecies allometric scaling","author":"Hunter","year":"2010"},{"key":"10.1016\/j.xphs.2026.104549_bib0010","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.molpharmaceut.3c00520","article-title":"Pharmacokinetics in penguins compared to other avian species: a review of enrofloxacin and voriconazole","volume":"20","author":"Woods","year":"2023","journal-title":"Mol Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104549_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2020.1711058","article-title":"An oral bait vaccination approach for the Tasmanian devil facial tumor diseases","volume":"19","author":"Flies","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.xphs.2026.104549_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.prevetmed.2010.11.018","article-title":"Efficacy of the boar-operated-system for deliver baits to feral swine","volume":"98","author":"Campbell","year":"2011","journal-title":"Prev Vet Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0013","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7589\/2017-01-013","article-title":"Using off-the-shelf technologies to mass manufacture oral vaccine baits for wildlife","volume":"53","author":"Corro","year":"2017","journal-title":"J Wildlife Dis"},{"key":"10.1016\/j.xphs.2026.104549_bib0014","first-page":"51","article-title":"Development of a long-life bait for control of stoats","author":"Henderson","year":"2002","journal-title":"DOC Sci Internal Series"},{"issue":"4","key":"10.1016\/j.xphs.2026.104549_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s10344-020-01389-8","article-title":"Tuning oral-bait delivery strategies for red deer in Mediterranean ecosystems","volume":"66","author":"Martinez-Guijosa","year":"2020","journal-title":"Eur J Wildl Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ps.1129","article-title":"Masking the taste of the conditioned taste aversion agent levamisole using an ion-exchange resin, for practical application in wildlife management","volume":"62","author":"Cotterill","year":"2006","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.xphs.2026.104549_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122284","article-title":"Pharmaceutics for free-ranging wildlife: case studies to illustrate considerations and future prospects","volume":"628","author":"McDowell","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104549_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1071\/WR06094","article-title":"Stability of cabergoline in fox baits in laboratory and field conditions","volume":"34","author":"McLean","year":"2007","journal-title":"Wildlife Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0019","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/etc.5528","article-title":"Do pharmaceuticals in the environment pose a risk to wildlife?","volume":"43","author":"Bean","year":"2024","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.xphs.2026.104549_bib0020","first-page":"1","article-title":"An updated review of the toxicology and ecotoxicology of sodium fluoroacetate (1080) in relation to its use as a pest control tool in New Zealand","author":"Eason","year":"2011","journal-title":"N Z J Ecol"},{"key":"10.1016\/j.xphs.2026.104549_bib0021","series-title":"Public Law 108-282","year":"2004"},{"issue":"12","key":"10.1016\/j.xphs.2026.104549_bib0022","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology \u2014 Drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns Gregory","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xphs.2026.104549_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114084","article-title":"Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines","volume":"181","author":"Wollmer","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104549_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jclinepi.2018.04.018","article-title":"Randomized controlled trials in pediatric patients had higher completion rates than adult trials: a cross-sectional study","volume":"100","author":"Dufetelle","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijpharm.2017.08.088","article-title":"Assessment of swallowability and palatability of oral dosage forms in children: report from an M-CERSI pediatric formulation workshop","volume":"536","author":"Ternik","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104549_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2020.08.014","article-title":"Swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications","volume":"156","author":"Freerks","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104549_bib0027","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpeds.2018.12.075","article-title":"Minitablets may be an acceptable alternative to liquid in infants and young children","volume":"206","author":"Batchelor","year":"2019","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.xphs.2026.104549_bib0028","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/archdischild-2022-325264","article-title":"Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study","volume":"108","author":"Klingmann","year":"2023","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0029","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/pharmaceutics15020594","article-title":"Pediatric mini-tablets: predicting the hidden risk of fill errors","volume":"15","author":"Gerberich","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2026.104549_bib0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/pharmaceutics13050730","article-title":"Children\u2019s preferences for oral dosage forms and their involvement in formulation research via EPTRI (European Paediatric Translational Research Infrastructure)","volume":"13","author":"Alessandrini","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2026.104549_bib0031","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41390-021-01920-w","article-title":"Taste function in children: normative values and associated factors","volume":"92","author":"van den Brink","year":"2022","journal-title":"Pediatr Res"},{"key":"10.1016\/j.xphs.2026.104549_bib0032","first-page":"17","article-title":"Evolving approaches to taste masking","volume":"49","author":"Challener","year":"2025","journal-title":"Pharmaceut Technol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104549_bib0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.18773\/austprescr.2016.071","article-title":"Paediatric pharmacokinetics and drug doses","volume":"39","author":"O'Hara","year":"2016","journal-title":"Aust Prescr"},{"key":"10.1016\/j.xphs.2026.104549_bib0034","doi-asserted-by":"crossref","unstructured":"Knopf A. Why some teens may need long-acting injectables. The Brown University Child and Adolescent Behavior Letter 2025;41(5):5\u20136. https:\/\/doi.org\/10.1002\/cbl.30867.","DOI":"10.1002\/cbl.30867"},{"issue":"Supplement_4","key":"10.1016\/j.xphs.2026.104549_bib0035","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1093\/cid\/ciac754","article-title":"Potential of long-acting products to transform the treatment and prevention of human immunodeficiency virus (HIV) in infants, children, and adolescents","volume":"75","author":"Abrams","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.xphs.2026.104549_bib0036","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0091270004267589","article-title":"Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis","volume":"44","author":"Burgos-Vargas","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104549_bib0037","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jvp.12038","article-title":"Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administration","volume":"36","author":"Kimble","year":"2013","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0039","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1647\/2017-281","article-title":"Pharmacokinetics of a single dose of oral and intramuscular meloxicam in African penguins (Spheniscus demersus)","volume":"32","author":"Morrison","year":"2018","journal-title":"J. Avian Med. Surg."},{"issue":"1","key":"10.1016\/j.xphs.2026.104549_bib0053","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1647\/2014-065","article-title":"Pharmacokinetics of a single dose of oral and subcutaneous meloxicam in Caribbean flamingos (Phoenicopterus ruber ruber)","volume":"30","author":"Lindemann","year":"2016","journal-title":"J Avian Med Surg"},{"key":"10.1016\/j.xphs.2026.104549_bib0054","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jvp.12923","article-title":"Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus (Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling","volume":"44","author":"Castineiras","year":"2021","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/jvim.12045","article-title":"Pharmacokinetics and safety of oral administration of meloxicam to foals","volume":"27","author":"Raidal","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"11","key":"10.1016\/j.xphs.2026.104549_bib0056","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2460\/ajvr.2004.65.1542","article-title":"Pharmacokinetics of meloxicam in plasma and urine of horses","volume":"65","author":"Toutain","year":"2004","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0057","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2885.2008.00958.x","article-title":"Pharmacokinetics and pharmacodynamics of meloxicam in piglets","volume":"31","author":"Fosse","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2026.104549_bib0058","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jvp.12170","article-title":"Pharmacokinetics of meloxicam in mature swine after intravenous and oral administration","volume":"38","author":"Pairis-Garcia","year":"2015","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2026.104549_bib0059","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jvp.13404","article-title":"Age-related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep","volume":"46","author":"Coskun","year":"2023","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.xphs.2026.104549_bib0040","series-title":"Essentials of Translational Pediatric Drug Development","first-page":"189","article-title":"Chapter 9 - application of preclinical juvenile animal models","author":"Hermans","year":"2024"},{"key":"10.1016\/j.xphs.2026.104549_bib0041","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/156720109789000483","article-title":"Controlled release drug delivery in farmed animals: commercial challenges and academic opportunities","volume":"6","author":"Rathbone","year":"2009","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104549_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124140","article-title":"Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders","volume":"657","author":"Rodr\u00edguez-Pombo","year":"2024","journal-title":"Int J Pharm"},{"issue":"25","key":"10.1016\/j.xphs.2026.104549_bib0043","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2174\/1381612829666230822090303","article-title":"Recent advances in the 3D printing of pharmaceuticals for veterinary treatments","volume":"29","author":"Beck","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.xphs.2026.104549_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/vetsci11110519","article-title":"Pharmacokinetics of meloxicam in different animal species: a comprehensive review","volume":"11","author":"de la Puente","year":"2024","journal-title":"Vet Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104549_bib0046","doi-asserted-by":"crossref","DOI":"10.2460\/ajvr.25.08.0288","article-title":"Pharmacological innovations for enhancing animal health","volume":"86","author":"Kimble","year":"2025","journal-title":"Am J Vet Res"},{"issue":"S1","key":"10.1016\/j.xphs.2026.104549_bib0047","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1002\/jcph.1834","article-title":"Physiologically based pharmacokinetic modeling and allometric scaling in pediatric drug development: where do we draw the line?","volume":"61","author":"Johnson","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2026.104549_bib0048","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/fvets.2026.1835903","article-title":"Reusable gelatin-based inks for 3D printing of veterinary gabapentin tablets: a sustainable approach","volume":"13","author":"Taylor","year":"2026","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104549_bib0049","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/pharmaceutics17060762","article-title":"Automated 3D printing-based non-sterile compounding technology for pediatric corticosteroid dosage forms in a health system pharmacy setting","volume":"17","author":"Bernhardt","year":"2025","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2026.104549_bib0050","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1021\/acsapm.2c01041","article-title":"Toward targeted invasive predator control: developing pH-responsive subcutaneous implants for native mammals","volume":"4","author":"Brewer","year":"2022","journal-title":"ACS Appl Polym Mater"},{"issue":"2","key":"10.1016\/j.xphs.2026.104549_bib0051","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cell.2009.10.001","article-title":"Common sense about taste: from mammals to insects","volume":"139","author":"Yarmolinsky","year":"2009","journal-title":"Cell"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:30:52Z","timestamp":1793277052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S0022354926003990"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104549","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Of mice and little humans: A comparison of the issues facing drug delivery to wildlife and pediatric patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104549"}}